| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS42001707 | EBV | ENSG00000196126.12 | protein_coding | HLA-DRB1 | No | No | 3123 | D7RIH8 P01911 P01912 Q29974 Q5Y7D1 X5DNQ0 |
| TVIS30020801 | HIV | ENSG00000196126.12 | protein_coding | HLA-DRB1 | No | No | 3123 | D7RIH8 P01911 P01912 Q29974 Q5Y7D1 X5DNQ0 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | HLA-DRB1 |
|---|---|
| DrugBank ID | DB05259 |
| Drug Name | Glatiramer |
| Target ID | BE0002416 |
| UniProt ID | P01911 |
| Regulation Type | binder |
| PubMed IDs | 15371592; 9574543 |
| Citations | Arnon R, Aharoni R: Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications. Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14593-8. Epub 2004 Sep 15.@@Fridkis-Hareli M, Strominger JL: Promiscuous binding of synthetic copolymer 1 to purified HLA-DR molecules. J Immunol. 1998 May 1;160(9):4386-97. |
| Groups | Approved; Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | PA449760 |
| ChEMBL | CHEMBL1201507 |
